Nick Tait
Director of Finance/CFO at Metrion Biosciences Ltd.
Profile
Nick Tait is the founder of The Great Little Pub Co. Ltd.
He is currently working as the Chief Financial Officer, Secretary & Director at Metrion Biosciences Ltd.
Nick Tait active positions
| Companies | Position | Start |
|---|---|---|
Metrion Biosciences Ltd.
 Metrion Biosciences Ltd. BiotechnologyHealth Technology Metrion Biosciences Ltd. is a contract research organization that specializes in providing drug discovery services to pharmaceutical and bioscience customers. Metrion Biosciences is based in Great Abington, UK and was founded in 2015. The British company offers a range of high-quality ion channel assays on a fee-for-service or collaboration basis, including an industry-leading panel of in vitro cardiac ion channel safety assays, translational native cell and phenotypic assays for neurological and cardiotoxicity testing, and a range of other ion channel screening services such as cell line development and optimization. Andrew Southan has been the CEO of the company since 2016. | Director of Finance/CFO | - |
Former positions of Nick Tait
| Companies | Position | End |
|---|---|---|
The Great Little Pub Co. Ltd.
 The Great Little Pub Co. Ltd. RestaurantsConsumer Services The Great Little Pub Co. Ltd. owns and operates pubs and restaurants. The company was founded by Nick Tait and is headquartered in Brighton, the United Kingdom. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
The Great Little Pub Co. Ltd.
The Great Little Pub Co. Ltd. RestaurantsConsumer Services The Great Little Pub Co. Ltd. owns and operates pubs and restaurants. The company was founded by Nick Tait and is headquartered in Brighton, the United Kingdom. | Consumer Services |
Metrion Biosciences Ltd.
Metrion Biosciences Ltd. BiotechnologyHealth Technology Metrion Biosciences Ltd. is a contract research organization that specializes in providing drug discovery services to pharmaceutical and bioscience customers. Metrion Biosciences is based in Great Abington, UK and was founded in 2015. The British company offers a range of high-quality ion channel assays on a fee-for-service or collaboration basis, including an industry-leading panel of in vitro cardiac ion channel safety assays, translational native cell and phenotypic assays for neurological and cardiotoxicity testing, and a range of other ion channel screening services such as cell line development and optimization. Andrew Southan has been the CEO of the company since 2016. | Health Technology |
- Stock Market
- Insiders
- Nick Tait
